Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

07 mars 2016 09h05 HE | Source: LifeMD, Inc.

ImmuDyne Pre-Announces Full Year 2015 Revenues Up 73%; Guides for $10M in Fiscal 2016

Fiscal 2015 Revenues Expected To Be Up 73% to $1.225 Million, Compared to Fiscal 2014Projecting $10 Million in Revenues for Fiscal 2016Focused on Cost Management and Profitability in Fiscal 2016 MT....
10 déc. 2015 08h30 HE | Source: LifeMD, Inc.

ImmuDyne Engages One Equity Research to Reach New Investors With Company’s Value Proposition

MT. KISCO, N.Y., Dec. 10, 2015 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) today announced that it has engaged One Equity Research LLC ("One Equity") to provide advisory services and research...
13 oct. 2015 08h30 HE | Source: LifeMD, Inc.

ImmuDyne and Innate Scientific Announce Collaboration and Licensing Agreement to Launch National Skin Care Line Based on ImmuDyne’s Yeast Beta Glucan Technology Portfolio

MT. KISCO, N.Y., Oct. 13, 2015 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD), a health, wellness and skincare company commercializing a portfolio of proprietary topical and orally delivered...
01 oct. 2015 08h30 HE | Source: LifeMD, Inc.

ImmuDyne Sales Continue to Improve, Sees Earnings Ahead

MT. KISCO, N.Y., Oct. 01, 2015 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) ImmuDyne today announced nine month revenues grew to $844,268 in 2015 from $554,509 in 2014. Revenues for the 3rd...
16 sept. 2015 09h34 HE | Source: LifeMD, Inc.

Sven Rohmann M.D., PhD, M.B.A. Joins the Board of Directors at Immudyne, as the Company Prepares to Announce a Lead Application for Its Proprietary Oral and Topical Delivery Technology

MT. KISCO, N.Y., Sept. 16, 2015 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) - announced today that Sven Rohmann M.D., PhD, M.B.A. has joined its Board of Directors. Previously, Dr....
02 avr. 2015 11h58 HE | Source: LifeMD, Inc.

ImmuDyne Progress Report

MT. KISCO, N.Y., April 2, 2015 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) announces 1st quarter revenues rose more than 50%, year over year, to approximately $288,000. Additionally, as reported...
26 mars 2015 12h48 HE | Source: LifeMD, Inc.

IPA Endorses ImmuDyne Line of Immune Support Supplements

MT. KISCO, N.Y., March 26, 2015 (GLOBE NEWSWIRE) -- Today, ImmuDyne (immd) announced that the Independent Pharmacy Alliance will endorse ImmuDyne's full line of Immune Support Products. IPA President...
10 févr. 2015 09h30 HE | Source: LifeMD, Inc.

ImmuDyne Hires Todd Goldman as Senior Vice President of Marketing and Sales

MT. KISCO, N.Y., Feb. 10, 2015 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) announced today the hiring of Todd Goldman as Senior Vice President of Marketing and Sales. ImmuDyne President and CEO,...
05 févr. 2015 09h50 HE | Source: LifeMD, Inc.

ImmuDyne Teams Again With HellaWella

MT. KISCO, N.Y., Feb. 5, 2015 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) and media partner HellaWella announced today the second published content ("An aging immune system puts you at higher risk...
26 janv. 2015 11h12 HE | Source: LifeMD, Inc.

ImmuDyne Teams With HellaWella

MT. KISCO N.Y., Jan. 26, 2015 (GLOBE NEWSWIRE) -- ImmuDyne, Inc. (OTCQB:IMMD) announced today that It has chosen HellaWella as a media partner. The first published content can be accessed...

Page précédente